Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: Involvement of 5-HT6 and 5-HT 2A receptor mechanisms

Psychopharmacology

Volumn 208, Issue 1, 2010, Pages 23-36

  Idris, Nagi ^a   Neill, Jo ^a   Grayson, Ben ^a   Bang Andersen, Benny ^b   Witten, Louise M ^b   Brennum, Lise Tøttrup ^b   Arnt, Jørn ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b H LUNDBECK A S   (Denmark)

Author keywords

5 HT 2A receptors; 5 HT6 receptors; Behaviour; Cognitive tests; PCP; Rat; Schizophrenia; Sertindole

Indexed keywords

3 PHENYLSULFONYL 8 (1 PIPERAZINYL)QUINOLINE; PHENCYCLIDINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 6 RECEPTOR; SERTINDOLE; VOLINANSERIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; EPISODIC MEMORY; FEMALE; LEARNING; LEARNING DISORDER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROBENZENES; IMIDAZOLES; INDOLES; MEMORY DISORDERS; PHENCYCLIDINE; PIPERIDINES; QUINOLINES; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; REVERSAL LEARNING; SCHIZOPHRENIA; SULFONES;

EID: 72649104250     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1702-5     Document Type: Article

References (67)

1. Z Abdul-Monim GP Reynolds JC Neill 2003 The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat J Psychopharmacol 17 57 65 10.1177/0269881103017001700 1:CAS:528:DC%2BD3sXjtVSjtbk%3D 12680740 (Pubitemid 36373141)
2. Z Abdul-Monim GP Reynolds JC Neill 2006 The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm Behav Brain Res 169 263 273 10.1016/j.bbr.2006.01.019 1:CAS:528:DC%2BD28XivVCls7w%3D 16500717
3. Z Abdul-Monim JC Neill GP Reynolds 2007 Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat J Psychopharmacol 21 198 205 10.1177/0269881107067097 1:CAS:528:DC%2BD2sXkt1Wksb0%3D 17329300 (Pubitemid 46280471)
4. A Abi-Dargham H Moore 2003 Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia Neuroscientist 9 404 416 10.1177/ 1073858403252674 1:CAS:528:DC%2BD3sXoslajtr4%3D 14580124 (Pubitemid 37204344)
5. J Addington D Addington L Gasbarre 2001 Neurocognitive and social functioning in schizophrenia and other diagnoses Schizophr Res 48 367 368 10.1016/S0920-9964(00)00103-1 1:STN:280:DC%2BD3MvgvFymtg%3D%3D 11295389 (Pubitemid 32274333)
6. PH Andersen JA Jansen EB Nielsen 1987 [3H]GBR12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site Eur J Pharmacol 144 1 6 10.1016/0014-2999(87)90002-1 1:CAS:528:DyaL1cXkvFaitw%3D%3D 3436357 (Pubitemid 18013338)
7. J Arnt T Skarsfeldt 1998 Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 63 101 10.1016/S0893-133X(97)00112-7 1:CAS:528:DyaK1cXht1GhsQ%3D%3D 9430133 (Pubitemid 28026679)
8. J Arnt B Bang-Anderson R Dias KP Bogeso 2008 Strategies for pharmacotherapy of schizophrenia Drugs Future 33 777 791 10.1358/dof.2008.033. 09.1236966 1:CAS:528:DC%2BD1MXltFahtg%3D%3D
9. JM Azorin N Strub H Loft 2006 A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia Int J Psychopharmacol 21 49 56 10.1097/01.yic.0000177020.26311.a7 (Pubitemid 43175123)
10. S Beraki R Diaz-Heijtz F Tai SO Ogren 2009 Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice Int J Neuropsychopharmacol 12 243 255 10.1017/S1461145708009152 1:CAS:528: DC%2BD1MXit1aht7o%3D 18684341
11. RM Bilder RS Goldman J Volavka P Czobor M Hoptman B Sheitman JP Lindenmayer L Citrome J McEvoy M Kunz M Chakos TB Cooper TL Horowitz JA Lieberman 2002 Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder Am J Psychiatry 159 1018 1028 10.1176/appi.ajp.159.6.1018 12042192 (Pubitemid 34586949)
12. RE Clark SM Zola LR Squire 2000 Impaired recognition memory in rats after damage to the hippocampus J Neurosci 20 8853 8860 1:CAS:528:DC%2BD3MXpslWn 11102494
13. LA Dawson HQ Nguyen P Li 2001 The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus Neuropsychopharmacology 25 662 668 10.1016/S0893-133X(01)00265-2 1:CAS:528:DC%2BD3MXnslCjsbw%3D 11682249 (Pubitemid 32995948)
14. 4 partial agonist properties: (III) Activity in models of cognition and negative symptoms Br J Pharmacol 151 266 277 10.1038/sj.bjp.0707160 17375085 (Pubitemid 46763037)
15. E Dere JP Huston MA de Souza Silva 2007 The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents Neurosci Biobehav Rev 31 673 704 10.1016/j.neubiorev.2007.01.005 1:CAS:528:DC%2BD2sXkvFOmtLY%3D 17368764 (Pubitemid 46670336)
16. M Didriksen J Arnt T Skarsfeldt 2007 Reversal of PCP-induced learning and acquisition deficits in the water maze after acute administration of sertindole and other antipsychotics Psychopharmacology 193 225 233 10.1007/s00213-007- 0774-3 1:CAS:528:DC%2BD2sXntFGqtLw%3D 17406859 (Pubitemid 47025022)
17. RJ Drake SW Lewis 2003 Insight and neurocognition in schizophrenia Schizophr Res 62 165 173 10.1016/S0920-9964(02)00382-1 12765757 (Pubitemid 36588715)
18. MJ Dunn S Kilcross 2006 Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance Behav Brain Res 175 271 277 10.1016/j.bbr.2006.08.028 1:CAS:528:DC%2BD28Xht1ersr7F 17027093 (Pubitemid 44750225)
19. Fleming K, Potkin SG, Binnema B, Keller DS, Alphs L, Panagides J (2007) Asenapine improves cognitive function in acute schizophrenia: a placebo-and risperidone-controlled trial. Presented at the 160th Annual Meeting of the American Psychiatric Association, May 19-24, 2007, San Diego, CA
20. O Franberg C Wiker MM Marcus A Konradsson K Jardemark B Schilstrom M Shahid EH Wong TH Svensson 2008 Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia Psychopharmacology (Berl.) 196 417 429 10.1007/s00213-007-0973-y 1:CAS:528:DC%2BD1cXht1Knsbw%3D (Pubitemid 351200428)
21. B Gallhofer P Jaanson A Mittoux P Tanghøj S Lis S Krieger 2007 Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol Pharmacopsychiatry 40 275 286 10.1055/s-2007-990291 1:CAS:528: DC%2BD1cXislyrug%3D%3D 18030652 (Pubitemid 350232820)
22. P Goetghebeur R Dias 2009 Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study Psychopharmacology 202 287 293 10.1007/s00213-008-1132-9 1:CAS:528: DC%2BD1MXht1ehtbo%3D 18392753 Epub 2008 Apr 8
23. Goldberg TE, Gold JM (1995) Neurocognitive deficits in schizophrenia. Blackwell, London
24. PS Goldman-Rakic SA Castner TH Svensson LJ Siever GV Williams 2004 Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacology 174 3 16 10.1007/s00213-004-1793-y 1:CAS:528:DC%2BD2cXmvVahtL0%3D 15118803
25. B Grayson NF Idris JC Neill 2007 Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat Behav Brain Res 184 31 38 10.1016/j.bbr.2007.06.012 1:CAS:528:DC%2BD2sXhtVOgtrjL 17675172 (Pubitemid 47404650)
26. Grayson B, Kurin A, Neill JC (2008) J Psychopharmacol Abstract supplement to volume 22(5):A16
27. MF Green 1996 What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 321 330 1:STN:280: DyaK287otVGqtA%3D%3D 8610818
28. PD Harvey H Meltzer GM Simpson SG Potkin A Loebel C Siu SJ Romano 2004 Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia Schizophr Res 66 101 113 10.1016/j.schres.2003.07.009 15061242 (Pubitemid 38041108)
29. K Hashimoto Y Fujita T Ishima S Chaki M Iyo 2008 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine Eur Neuropsychopharmacol 18 414 421 10.1016/j.euroneuro.2007.07.009 1:CAS:528:DC%2BD1cXlsFOiu74%3D 17804206 (Pubitemid 351608551)
30. PD Hatcher VJ Brown DS Tait S Bate P Overend JJ Hagan DN Jones 2005 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats Psychopharmacology (Berl.) 181 253 259 10.1007/s00213-005-2261-z 1:CAS:528:DC%2BD2MXhtFCrtL3L (Pubitemid 41492195)
31. WD Hirst TO Stean DC Rogers D Sunter P Pugh SF Moss SM Bromidge G Riley DR Smith S Bartlett CA Heidbreder AR Atkins LP Lacroix LA Dawson AG Foley CM Regan N Upton 2006 SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models Eur J Pharmacol 553 109 119 10.1016/j.ejphar.2006.09.049 1:CAS:528:DC%2BD28Xht1Ciu7nO 17069795 (Pubitemid 44779592)
32. J Hyttel JB Nielsen G Nowak 1992 The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies) J Neural Transm [Gen Sect] 89 61 69 10.1007/BF01245352 1:CAS:528:DyaK3sXntFY%3D
33. NF Idris P Repeto JC Neill CH Large 2005 Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat Psychopharmacology 179 336 348 10.1007/s00213-004-2058-5 1:CAS:528:DC%2BD2MXjtV2hsro%3D 15645224
34. JD Jentsch JR Taylor 2001 Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats Neuropsychopharmacology 24 66 74 10.1016/S0893-133X(00)00174-3 1:CAS:528:DC%2BD3cXosFeqs70%3D 11106877
35. JD Jentsch A Tran D Le KD Youngren RH Roth 1997 Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat Neuropsychopharmacology 17 92 99 10.1016/S0893-133X(97)00034-1 1:CAS:528:DyaK2sXlt1Olsro%3D 9252984 (Pubitemid 27326870)
36. PB Jones TR Barnes L Davies G Dunn H Lloyd KP Hayhurst RM Murray A Markwick SW Lewis 2006 Randomized controlled trial of effect on quality of life of second-vs first-generation antipsychotic drugs in schizophrenia. Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1) Arch Gen Psychiatry 63 1079 1087 10.1001/archpsyc.63.10.1079 1:CAS:528:DC%2BD28XhtFKhtrzP 17015810 (Pubitemid 44498387)
37. JM Kane CA Tamminga 1997 Sertindole (serdolect): preclinical and clinical findings of a new atypical antipsychotic Expert Opin Investig Drugs 6 1729 1741 10.1517/13543784.6.11.1729 1:CAS:528:DyaK2sXnsFaitbg%3D 15989577 (Pubitemid 27488037)
38. S Kapur SC VanderSpek BA Brownlee JN Nobrega 2003 Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 625 631 10.1124/jpet.102.046987 1:CAS:528:DC%2BD3sXjt12murk%3D 12606608 (Pubitemid 36459179)
39. RS Keefe SG Silva DO Perkins JA Lieberman 1999 The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis Schizophr Bull 25 201 222 1:STN:280:DyaK1MzktlWitA%3D%3D 10416727
40. RS Keefe RM Bilder SM Davis PD Harvey BW Palmer JM Gold HY Meltzer MF Green G Capuano TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins CE Davis JK Hsiao JA Lieberman 2007 Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial Arch Gen Psychiatry 64 633 647 10.1001/archpsyc.64.6.633 1:CAS:528:DC%2BD2sXntlOgtLk%3D 17548746 (Pubitemid 46878665)
41. MB Knable DR Weinberger 1997 Dopamine, the prefrontal cortex and schizophrenia Psychopharmacology 11 123 131 10.1177/026988119701100205 1:CAS:528:DyaK2sXmtlOgtrc%3D (Pubitemid 27252643)
42. SW Lewis TRE Barnes L Davies RM Murray G Dunn KP Hayhurst A Markwick H Lloyd PB Jones 2006 Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia Schizophr Bull 32 715 723 10.1093/schbul/sbj067 16540702 (Pubitemid 44412859)
43. Leysen JE (2000) Receptor profile of antipsychotics. In: Ellenbroek BA, Cools AR (eds) Atypical antipsychotics. Birkhäuser, Berlin, pp 57-81
44. Liddle P (2000) Functional brain imaging of schizophrenia. In: Reveley MA, Deakin JFW (eds) The psychopharmacology of schizophrenia. Oxford University Press, New York, pp 41-55
45. F Loiseau A Dekeyne MJ Millan 2008 Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex Psychopharmacology 196 93 104 10.1007/s00213-007-0934-5 1:CAS:528:DC%2BD1cXhsV2kurc%3D 17922111
46. SL McLean JP Beck ML Woolley JC Neill 2008 A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats Behav Brain Res 189 152 158 10.1016/j.bbr.2007.12.029 1:CAS:528:DC%2BD1cXjtleisbY%3D 18282619
47. SL McLean NF Idris ML Woolley JC Neill 2009 D1 receptor activation improves PCP-induced cognitive deficits in animal models: implications for mechanisms of cognition in schizophrenia Eur Neuropsychopharmacol 19 440 450 10.1016/j.euroneuro.2009.01.009 1:CAS:528:DC%2BD1MXltVOnsrc%3D 19268547
48. HY Meltzer SR McGurk 1999 The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr Bull 25 233 255 1:STN:280:DyaK1MzktlWiug%3D%3D 10416729
49. A Mørk LM Witten J Arnt 2009 Effect of sertindole on extracellular dopamine, acetylcholine and glutamate in the medial prefrontal cortex of conscious rats; a comparison with risperidone and exploration of mechanisms involved Psychopharmacology 206 39 49 10.1007/s00213-009-1578-4 19506838
50. JC Neill M Shahid EHF Wong NF Idris 2006 Comparison of the efficacy of asenapine, risperidone and olanzapine to improve a reversal learning deficit in the rat Schiz Res 81 105 106
51. S Nyberg L Farde 2000 Non-equipotent doses partly explain differences among antipsychotics-implications of PET studies Psychopharmacology 148 22 23 10.1007/s002130050020 1:CAS:528:DC%2BD3cXhtFemtrw%3D 10663413
52. S Nyberg H Olsson U Nilsson E Maehlum C Halldin L Farde 2002 Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole Psychopharmacology 162 37 41 10.1007/s00213-002-1083-5 1:CAS:528:DC%2BD38Xmt1CisrY%3D 12107615 (Pubitemid 34639554)
53. C O'Grada T Dinan 2007 Executive function in schizophrenia: what impact do antipsychotics have? Hum Psychopharmacol 22 397 406 10.1002/hup.861 17579928 (Pubitemid 47316124)
54. JS Rodefer TN Nguyen JJ Karlsson J Arnt 2008 Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT(6) receptor antagonist: comparison among antipsychotics Neuropsychopharmacology 33 2657 2666 10.1038/sj.npp.1301654 1:CAS:528: DC%2BD1cXhtFWhs7zO 18094666
55. CJ Schmidt GM Fadayel 1995 The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat Eur J Pharmacol 273 3 273 279 10.1016/0014-2999(94)00698-7 1:CAS:528: DyaK2MXjsFantrw%3D 7737334
56. PK Smith RI Krohn GT Hermanson AK Mallia FH Gartner MD Provenzano EK Fujimoto NM Goeke BJ Olson DC Klenk 1985 Measurement of protein using bicinchoninic acid Ann Biochem 150 76 85 10.1016/0003-2697(85)90442-7 1:CAS:528:DyaL2MXlsFKksL0%3D (Pubitemid 16258399)
57. S Snigdha JC Neill 2008 Efficacy of antipsychotics to reverse phencyclidine induced social interaction deficits in female rats-A preliminary investigation Behav Brain Res 187 489 494 10.1016/j.bbr.2007.10.012 1:CAS:528:DC%2BD1cXotlygtg%3D%3D 18037171
58. S Snigdha JC Neill 2008 Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors Behav Brain Res 191 1 26 31 10.1016/j.bbr.2008.03.018 1:CAS:528:DC%2BD1cXmtVWrtbw%3D 18453008
59. S Snigdha J Neill M Shahid L Cruise B Henry 2007 Brain-derived neurotrophic factor downregulation in rat brain following sub-chronic phencyclidine administration Eur Neuropsychopharmacol 17 Suppl. 4 S258 10.1016/S0924-977X(07)70353-X
60. Snigdha S, Li Z, Dai J, Shahid M, Neill JC, Meltzer H (2008c) Effect of PCP to attenuate DA efflux in rats performing the object recognition task: an in vivo investigation. Program No. 791.4/TT40. 2008 Neuroscience Meeting Planner. Society for Neuroscience, Washington, 2008 (Online)
61. Stuchlik A, Petrasek T, Vales K (2009) Effect of alpha1-adrenergic antagonist prazosin on behavioral alterations induced by MK-801 in a spatial memory task in Long Evans rats. Physiol Res (in press)
62. JS Sutcliffe K Marshall JC Neill 2007 Influence of gender on working and spatial memory in the novel object recognition task in the rat Behav Brain Res 177 117 125 10.1016/j.bbr.2006.10.029 1:STN:280:DC%2BD2s%2FisValtA%3D%3D 17123641 (Pubitemid 46054189)
63. CA Tamminga JM Kane 1997 Olanzapine (Zyprexa): characteristics of a new antipsychotic Expert Opin Investig Drugs 6 1743 1752 10.1517/13543784.6.11.1743 1:CAS:528:DyaK2sXnsFaitbk%3D 15989578 (Pubitemid 27488038)
64. N Upton TT Chuang AJ Hunter DJ Virley 2008 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease Neurotherapeutics 5 458 469 10.1016/j.nurt.2008.05.008 1:CAS:528:DC%2BD1cXhtVOgtLrJ 18625457 (Pubitemid 351952494)
65. BD Winters LM Saksida TJ Bussey 2008 Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval Neurosci Biobehav Rev 32 1055 1070 10.1016/j.neubiorev.2008.04.004 18499253
66. W Zhang FP Bymaster 1999 The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors Psychopharmacology 141 3 267 278 10.1007/s002130050834 1:CAS:528:DyaK1MXotlCnug%3D%3D 10027508 (Pubitemid 29196076)
67. DL Zimbroff JM Kane CA Tamminga DG Daniel RJ Mack PJ Wozniak TB Sebree BA Wallin KB Kashkin 1997 Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group Am J Psychiatr 154 782 791 1:STN:280:DyaK2szhtVegug%3D%3D 9167505